Intravenous Acetaminophen Use With Bariatric Surgery on Morbidly Obese Patients

• Status: Terminated
• Trial end date: 2013-07-01
• Target enrollment: 0
• Participant gender: All

Summary

Bariatric patients usually require the use of either intravenous or oral opioid medications. The use of opioids, however, is often associated with side-effects such as nausea, sedation pruritus, urinary retention and respiratory depression with often delay patient discharge. This study makes use of intravenous acetaminophen , a non-opioid analgesic preoperatively to determine if this will decrease the use of opioids post-operatively for pain management in morbidly obese patients undergoing laparoscopic bariatric surgery.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Saint Francis Care
• Treatments: Acetaminophen

Criteria

Inclusion Criteria:

• Morbidly Obese and body mass index (BMI) of 35

• Between ages 20-17

• Candidates for Laparoscopic Bariatric Surgery

Exclusion Criteria:

• know hypersensitivity to acetaminophen or opioids

• impairment in liver function

• renal dysfunction

• mental retardation